ONCOZENGE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.635 SEK | +4.15% |
|
-1.89% | +17.64% |
| 21/05 | OncoZenge AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 08/04 | Oncozenge AB Appoints Paolo Bossi as Member of the Advisory Board | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 39.99L | - | - | - | - | - | |
| 73TCr | ||||||
| 60TCr | ||||||
| 35TCr | ||||||
| 33TCr | ||||||
| 28TCr |
- Stock Market
- Equities
- ONCOZ Stock
- Charts OncoZenge AB
- Sector Chart
